Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
Recruiting
Phase 4
Interventional Study
ERAS
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 20 – 60
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 98 (estimated)
- Sponsor
- Aga Khan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ASA physical status I, II, and III
* Patients scheduled for elective laparoscopic gynecological surgeries
Exclusion Criteria:
* Refusal to participate
* History of allergy or contraindication to study drugs
* Patients in which procedure converted to open surgery
* Diagnostic…
Contacts